Viewing StudyNCT00301366



Ignite Creation Date: 2024-05-05 @ 4:43 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00301366
Status: COMPLETED
Last Update Posted: 2014-08-19
First Post: 2006-03-08

Brief Title: The Safety and Tolerability of Alpha-1 Modified Process MP In Subjects With Alpha-1-antitrypsin AAT Deficiency
Sponsor: Grifols Therapeutics LLC
Organization: Grifols Therapeutics LLC

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-06
Start Date Type: None
Primary Completion Date: 2007-03
Primary Completion Date Type: ACTUAL
Completion Date: 2007-03
Completion Date Type: ACTUAL
First Submit Date: 2006-03-08
First Submit QC Date: March 8 2006
Study First Post Date: 2006-03-10
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2014-08-19
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-07-30
Last Update Post Date: 2014-08-19
Last Update Post Date Type: ESTIMATED